Syngene International Limited (NSE:SYNGENE)
India · Delayed Price · Currency is INR 639.80
-2.55 (-0.40%)
At close: Dec 5, 2025
Syngene International Market Cap
Syngene International has a market cap or net worth of 254.7 billion as of December 5, 2025. Its market cap has decreased by -24.01% in one year.
Market Cap
254.70B
Enterprise Value
249.61B
Revenue
37.47B
Ranking
n/a
PE Ratio
58.61
Stock Price
639.80
Market Cap Chart
Since August 11, 2015, Syngene International's market cap has increased from 62.11B to 254.70B, an increase of 310.08%. That is a compound annual growth rate of 14.64%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 254.70B | -25.39% |
| Dec 31, 2024 | 341.40B | 22.54% |
| Dec 29, 2023 | 278.60B | 19.79% |
| Dec 30, 2022 | 232.57B | -5.39% |
| Dec 31, 2021 | 245.81B | -3.08% |
| Dec 31, 2020 | 253.62B | 100.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.33T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.22T |
| Apollo Hospitals Enterprise | 1.03T |
| Zydus Lifesciences | 940.78B |
| Mankind Pharma | 910.38B |
| Aurobindo Pharma | 702.13B |
| Fortis Healthcare | 678.14B |